// App-Quantinova.ai

137 : High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment

Researchers

Presenter

  • Kylee L Martens

Principal Investigators

  • Wilson L da Costa Jr

  • Chris Davis

  • Madeline Kesten

  • Stephanie J. Lee

  • Neil A. Zakai

  • David A. Garcia

  • Ang Li

Medical Centers

  • Hematology / Medicine, University of Washington School of Medicine, Seattle, WA

  • Division of Epidemiology and Population Science, Baylor College of Medicine, Houston, TX

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Department of Medicine and Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Colchester, VT

  • Division of Hematology, University of Washington School of Medicine, Seattle, WA

  • Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved